Mason Marks, Attorney
Dr. Mason Marks advises clients on state and federal controlled substance regulation and licensing. He is a law professor at the University of New Hampshire Franklin Pierce School of Law, a Senior Fellow at the Petrie-Flom Center at Harvard Law School, and an affiliated fellow at the Information Society Project at Yale Law School.
An expert on the fast-emerging psychedelics industry, Mason has advised not only commercial clients but also city, state, and federal officials on this rapidly evolving regulatory landscape. In 2021, Governor Kate Brown appointed him to the Oregon Psilocybin Advisory Board, which is working with the Oregon Health Authority to establish the nation’s first regulated psilocybin services industry. He chairs the Board’s Licensing Subcommittee and serves on its Products Subcommittee.
Mason’s academic writing has been published or will soon be published in the Duke Law Journal, the U.C. Irvine Law Review, the U.C. Davis Law Review, the Administrative Law Review, and the Yale Journal of Law and Technology. He has written about psychedelics and drug policy for Slate, Gizmodo, the Seattle Times, and The Oregonian, and his legal commentary has been featured by media outlets including The New York Times, The Wall Street Journal, The Washington Post, ABC News, and NPR’s “All Things Considered”.
Mason studied Biology at Amherst College before obtaining a medical degree at Tufts University and a law degree from Vanderbilt Law School. He practiced intellectual property law in the San Francisco Bay Area, where he advised clients on licensing and patent prosecution. Before becoming a law professor, he completed academic fellowships at the Information Society Project at Yale Law School and the Information Law Institute at New York University. At Yale, he served as Managing Editor of the Yale Journal of Health Policy, Law, and Ethics.
A resident of Portland, Oregon, Mason divides his time between New England and the Pacific Northwest. He enjoys travel, hiking, and exploring the Oregon wilderness.
More About Mason
Oregon psilocybin rules shape who can provide and access care, Oregon Public Broadcasting, June 9, 2022.
Oregon Psilocybin: Ready to Launch, Harris Bricken webinar, April 7, 2022.
Protecting Sincere Psychedelic Churches: Chacruna’s Guide to the Law and Best Practices, Chacruna Institute, December 15, 2021.
Ethics in Psychedelic Therapy and Research, Harvard Law School, November 18, 2021.
Technology in Psychedelic Assisted Therapy, McLean Hospital Technology in Psychiatry Online Summit, Belmont, MA, October 27 – 29, 2021.
Panelist for Psychedelic Patents May be Bad for Your Health, Chacruna Institue, September 15, 2021.
Panelist at the Symposium on Decriminalizing Psychedelics, Seattle, WA, September 8, 2021.
Panelist on Psychedelic M&A Trends, 2021 Psychedelic Opportunity Virtual Summit, June 22, 2021.
Evidence Based Drug Policy for Twenty-First Century America, organized panel for 44th Annual Health Law Professors Conference (with Stacey Tovino, Leo Beletsky, and Jennifer Oliva), Northeastern University School of Law, Boston, MA, June 7, 2021.
Regulating Novel Drug Therapies for Mental Illness, Presenter, National Institutes of Health, Bethesda, MD, June 10, 2021.
Biosupremacy: Big Data, Antitrust, and Monopolistic Power Over Human Behavior, Presenter, Tilting Perspectives 2021: Regulating in Times of Crisis, Tilburg University School of Law, Tilburg, Netherlands, May 19, 2021.
Mental Health Moonshot: Unlocking Federal Funding for Experimental Therapies, Presenter, Harvard Law School, Cambridge, MA, April 12, 2021.
Artificial Intelligence Based Suicide Prediction, Presenter, U.S. Department of Health and Human Services, Washington, DC, April 5, 2021.
Telehealth: Quality, Privacy, and Access, Moderator, Harvard Law School, Cambridge, MA, April 7, 2021.
Addressing the Overdose Epidemic: Substance Use Policy for the Biden Administration, Moderator, Harvard Law School, Cambridge, MA, March 24, 2021.
Privatizing Public Health, Moderator, Harvard Law School, Cambridge, MA, March 17, 2021.
Regulating Novel Psychoactive Drug Therapies, Presenter, National Academies of Science, Medicine, and Engineering, Washington, DC, March 9, 2021.
Biosupremacy: Big Data, Antitrust, and Monopolistic Power Over Human Behavior, Presenter, Master Class with Andrew Murray, TMC Asser Institute, The Hague, Netherlands, March 5, 2020.
Automating Public Health and Safety, Presenter, Technology and the Law: Examining and Addressing Bias, Boston University Journal of Science and Technology, Boston, MA, February 19, 2021.
People are the Lifeblood of Innovation, Presenter, 18th Annual Works-in-Progress Intellectual Property Colloquium (WIPIP 2021), hosted by Texas A&M, University of Utah, and American University School of Law, February 18, 2021.
Biosupremacy: Data, Antitrust, and Monopolistic Power Over Human Behavior, Presenter, Junior Scholars Workshop, ClassCrits: A Network for Critical Analysis of Law and Economic Inequality, January 22, 2021.
Biosupremacy: Data, Antitrust, and Monopolistic Power Over Human Behavior, Presenter, Privacy Research Group, NYU Law School, New York, NY, January 22, 2021.
Federalism and State Drug Decriminalization Measures, Presenter, University of Washington School of Law, Seattle, WA, December 12, 2020.
Biopower and the Quest for Biosupremacy, Presenter, Health Law Roundtable, Center for Health Policy and Law, Northeastern University School of Law, Boston, MA, November 18, 2020.
The Right to Digital Self-Defense, Presenter, Regulation, Policy, and Practice, Yale Privacy Lab, Yale Law School, New Haven, CT, November 14, 2020.
Controlled Substance Regulation After the 2020 Election, Presenter, Program on Regulation, Therapeutics, and Law, Harvard Medical School, Boston, MA, November 11, 2020.
Biosupremacy, Presenter, Rocky Mountain Junior Scholars Conference, University of Utah S.J. Quinney College of Law, Salt Lake City, UT, November 6, 2020.
Recent legislative developments, Presenter, Psychedelic Medicine: Past, Present, and Future, Yale Psychedelic Science Group, Yale School of Medicine, New Haven CT, November 4, 2020.
Bias in Artificial Intelligence Based Mental Health Predictions, Presenter, Technology in Psychiatry Summit, McLean Hospital (Harvard Medical School’s psychiatric teaching hospital), Belmont, MA, October 30, 2020.
Social Justice and the Future of Psychopharmacology, Organizer and Moderator, Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Cambridge, MA, October 28, 2020.
Health & Technology Policy 2020, Conference Organizer and Moderator, Gonzaga University School of Law, Spokane, WA, October 9, 2020.
Biosupremacy, Presenter, Big Tech and Antitrust Conference, Yale Law School, New Haven, CT, October 3, 2020.
Controlled Substance Regulation for the COVID-19 Mental Health Crisis, Presenter, Health Law, Bioethics, and Biotechnology Workshop, Harvard Law School, Cambridge, MA, September 28, 2020.
Techwashed: Algorithms, Agency, and Accountability in the Information Age, Moderator, Gonzaga University School of Law, Spokane, WA, September 23, 2020.
Emergency Access to Schedule 1 Controlled Substances, Presenter, University of California, San Francisco School of Medicine, San Francisco, CA, August 7, 2020.
Panel Discussion on Careers in Law and Medicine, Panelist, Harvard Medical School, Boston, MA, July 8, 2020.
Health Data in the Information Age, Presenter, Vrije Universiteit Brussel, Privacy Hub, Brussels, Belgium, June 25, 2020.
Health Privacy in the Information Age, Moderator and Presenter, Privacy Law Scholars Conference (PLSC), Washington, DC, June 4, 2020.
Digital Phenotyping, Presenter, Ethical, Legal, and Social Implications of Deep Phenotyping Research, Harvard Medical School, Boston, MA, May 8, 2020.
Pandemic Privacy: A Conversation About Digital Surveillance, Presenter, Social Justice Fridays at the Center for Civil & Human Rights, Gonzaga University School of Law, Spokane, WA, April 17, 2020.
Introducing the Health & Technology Policy Project, Presenter, Center for Law, Ethics & Commerce, Gonzaga University School of Law, Spokane, WA, April 7, 2020.
Digital Phenotyping, Presenter, Yale Law School, New Haven, CT, March 26, 2020.
Emergent Medical Data, Presenter, Faculty Scholarship Series, University of Washington School of Law, Seattle, WA, March 5, 2020.
Emergent Medical Data, Presenter, Law and the Biosciences Workshop, Stanford Law School, Stanford, CA, February 18, 2020.
Emergent Medical Data, Presenter, Faculty Scholarship Series, Seattle University School of Law, Seattle, WA, January 28, 2020.
The Great Patent Eligibility Debate of 2019, Presenter, Second Annual Social Justice Conference: Medicine, Music, and Mascots, Gonzaga University School of Law, September 20, 2019.
Online Harm Reduction Can Do More Harm Than Good, Presenter, Ethics, Oversight, and Committees for AI, Big Data Institute, University of Oxford, Oxford, UK, May 10, 2019.
Sidewalk Wars: Regulating Autonomous Delivery Robots, We Robot 2019, University of Miami School of Law, Miami, FL, April 11, 2019.
Artificial Intelligence for Suicide Prediction, Presenter, Northeast Privacy Scholars Workshop, Fordham Law School, New York, NY, November 9, 2018.
Artificial Intelligence for Suicide Prediction, Presenter, The Law and Policy of AI, Robotics, and Telemedicine in Healthcare, Yale Law School, New Haven, CT, November 2, 2018.
Using AI to Infer Health Data from Consumer Behavior, Presenter, The ABCs of Modern Technological Challenges: AI, Blockchain, Cyber, and More, Yale Law School, New Haven, CT, June 4, 2018.
Algorithmic Disability Discrimination: How Corporate Mining of Emergent Medical Data Promotes Inequality, Presenter, Beyond Disadvantage: Disability, Law, and Bioethics, Harvard Law School, Cambridge, MA, June 1, 2018.
The Legal Duties of Companies Using AI to Collect Consumer Medical Data, Presenter, Artificial Intelligence and Law Conference, Seton Hall Law School, Newark, NJ, April 20, 2018.
Mining Health Data from Social Media, Presenter, Seton Hall Technology and Law Faculty Retreat, Seton Hall Law School, Newark, NJ, April 6, 2018.
Legal Obstacles to the Study and Clinical Use of Psychedelic Drugs, Presenter, Yale Medical School Department of Psychiatry, New Haven, CT, December 13, 2017.
Bioengineered Human Tissues and the Future of Medicine, Presenter, Science, Technology, and Utopian Visions, Yale University Whitney Humanities Center, New Haven, CT, November 1, 2017.
Artificial Intelligence in Healthcare, Guest Lecturer, Law and Artificial Intelligence, University of Minnesota Law School, Minneapolis, MN, October 24, 2017.
Patenting Bioengineered Human Tissues and Related Technologies, Presenter, American Bar Association Midyear Meeting, San Diego, CA, February 5, 2016.
Patenting Organs on Chips: A Hot Topic in Biotechnology, Presenter, Meeting of American Bar Association Science and Technology Committee Leadership, Del Mar, CA, January 23, 2016.
The 18 Power Players Shaping Oregon’s Psychedelic-Mushroom Future, Business Insider, June 15, 2022.
Oregon Psilocybin Rules Shape Who Can Provide and Access Care, OPB, June 9, 2022.
Oregon Has Legalized Psilocybin Therapy—So When Can I Take Magic Mushrooms?, Portland Mercury, April 18, 2022.
Psilocybin Regulations Bill Advancing In Oregon Senate, Ganjapreneur, February 23, 2022.
Oregon proposes only using one type of mushroom for new psilocybin system, and no pills, Oregon Public Broadcasting, February 8, 2022.
Should psychedelics be more widely available?, The Economist, January 28, 2022.
Psilocybin Services Would Be Legalized In Washington State Under New Bill, Marijuana Moment, January 6, 2022.
Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property, STAT, October 26, 2021.
Seattle bid to decriminalize psychedelics could have ‘profound’ effect on treating addiction, My Northwest, September 14, 2021.
DEA Proposes Quotas For Increase in Research Psilocybin, Truffle Report, September 2, 2021.
Seattle Should Decriminalize All Drugs, City Task Force On Overdose Crisis Recommends, Marijuana Moment, September 1, 2021.
Why Thailand Just Decriminalized a Plant That the US Has Tried To Ban, Vice, August 26, 2021.
Portland Activists Push To Decriminalize Psychedelics Cultivation, Gifting And Community Ceremonies, Marijuana Moment, August 20, 2021.
Covid-Induced Telehealth Boom in East Africa Is Picking Up Pace, Bloomberg, August 19, 2021.
Amazon Hit With €746M Privacy Fine From EU Regulators, Law360, July 30, 2021.
Oregon State Board Says Psilocybin Is Effective At Treating Certain Mental Health Condition, Marijuana Moment, July 29, 2021.
Can LSD Treat Food Allergies? We Don’t Know, But It’s Already Been Patented, Vice, July 1, 2021.
Police halt drug possession arrests as they await a major rewrite of Washington’s drug laws after Supreme Court ruling, Spokesman Review, April 18, 2021.
Telehealth works, but upgrade is still needed, say experts, Harvard Gazette, April 8, 2021.
Legal marijuana movement builds as more states change laws, ABC News, April 8, 2021.
Why Amazon’s ‘doctor Alexa’ may not be what the world ordered, Telegraph, December 14, 2020.
Marijuana legalization successes pave way for national conversation on drug law, ABC News, November 13, 2020
Panelists Advocate for Psychedelics Decriminalization in Law School Webinar, Harvard Crimson, October 29, 2020
How conservative South Dakota could be at the forefront of legalizing marijuana, ABC News, October 22, 2020.
Justice Department sues Google, accusing tech giant of illegal monopoly, Spokesman Review, October 10, 2020.
Health Data After COVID-19: More Laws, Less Privacy, Wall Street Journal, September 10, 2020.
Health officials providing more information about COVID-19 patients, Spokesman Review, April 6, 2020.
Big Tech Eyes the Pandemic, What’s Next: TBD [Slate Magazine’s technology podcast], March 20, 2020.
Trump’s DNA is Reportedly For Sale. Here’s What Someone Could Do With It, OneZero, February 13, 2020.
How AI could combat the spread of China’s deadly coronavirus, Telegraph, January 22, 2020.
California’s landmark privacy law will have ‘subtle’ effect on hospitals, Modern Healthcare, December 13, 2019.
Mental health apps are scooping up your most sensitive data. Will you benefit?, STAT, September 20, 2019.
The DEA says it will make it easier to study weed, but experts say there’s a catch, Vice News, August 28, 2019.
New Zealand Attack: Local reaction and its spread on social media, Radio Boston, March 15, 2019.
How to keep your information safe after taking a DNA test, Now National News, February 18, 2019.
Can AI help Instagram get rid of dangerous and abusive images?, Telegraph, February 8, 2019.
Legalization of Psychedelic Substances, JAMA Network, December 21, 2021.
Warning: Oregon Legalized Supported Adult Use of Psilocybin, Not Psychedelic Therapy, Chacruna, December 14, 2021.
Psychedelic therapy: a roadmap for wider acceptance and utilization, Nature Medicine Journal, October 4, 2021.
FDA’s kratom ban would harm the public and damage the agency’s credibility, Stat News, August 23, 2021.
Blockchain and the FDA’s Blueprint for a New Era of Smarter Food Safety, Stanford RegTrax Blockchain Initiative, Stanford Law School, March 10, 2021.
Inside the Fight to Legalize Psilocybin Therapy in Oregon, Gizmodo, October 22, 2020.
Why D.C. and Oregon Should Vote Yes on Psychedelics, Slate, October 19, 2020.
Readers Respond: A ‘yes’ for Measure 109, The Oregonian, October 1, 2020.
Amid COVID-19, the Americans with Disabilities Act Turns 30. It Needs to be Updated, Los Angeles Times, July 25, 2020.
Websites Need to Become ‘Places of Public Accommodation’ Under the Americans with Disabilities Act, The Hill, June 8, 2020.
Experimental Drug Could Curb Emerging COVID Mental Health Crisis, Northwestern University Law Review of Note, June 5, 2020.
Drug Regulation for the COVID Mental Health Crisis, Harvard Law and Policy Review Blog, May 30, 2020.
A Right to Digital Self-Defense Will Help Prevent Abuse of COVID-19 Surveillance Apps (with Ido Kilovaty), The Hill, April 19, 2020.
You Shouldn’t Have to Give Google Your Data to Access a COVID-19 Test, Slate, March 17, 2020.
The Right Questions to Ask About Google’s Project Nightingale, Slate, November 20, 2019.
The Right Questions to Ask About Google’s Project Nightingale, Slate, November 20, 2019.
Tech companies’ dangerous practice: using AI to mine hidden health data, STAT First Opinion, September 17, 2019.
DEA’s Restrictive Cannabis Proposal Will Hinder Research and Favor Corporate Interests Seattle Times, September 13, 2019.
At Cannabis Shops, Face Recognition is Already a Thing, Motherboard, August 2, 2019.
Online Content Moderation as Public Health Regulation, Harvard Law School Bill of Health, June 22, 2019.
Censoring Self-Harm on Facebook Might Do More Harm Than Good, Motherboard, March 1, 2019.
Facebook is predicting if you’ll kill yourself. That’s wrong, Guardian, January 30, 2019.
Suicide prediction technology is revolutionary. It badly needs oversight, Washington Post, December 20, 2018.
Artificial Intelligence for Suicide Prediction, Balkinization, October 30, 2018.
Die vermessung der psyche – Ein feature über digitale therapeuten, German Public Radio, April 24, 2019.
FDA Uses Novel Computer Simulation to Guide Kratom Policy, Harvard Law School Bill of Health, February 8, 2018.
The Opioid Crisis Requires Evidence-Based Solutions, Parts I, II, and III, Harvard Law School Bill of Health, December 18, 2017.
Emergent Medical Data, Harvard Law School Bill of Health, October 11, 2017.
Want Your Marijuana Startup to Succeed? Study Patent Law, WIRED, November 5, 2016.
Member of California Bar Association
Board Member and Chair of Licensing Subcommittee, Oregon Psilocybin Advisory Board.
Board of Advisors, Plant Medicine Healing Alliance, Portland, OR.
First-Year Law Student Professional Mentor, University of Washington School of Law, Seattle, WA.